BRIEF published on 03/03/2026 at 19:40, 7 months 29 days ago ABIONYX: Information on voting rights and shares as of February 28, 2026 Euronext Paris Share Capital Voting Rights AMF ABIONYX
PRESS RELEASE published on 03/03/2026 at 19:35, 7 months 29 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares on Euronext Paris. Company focuses on innovative medicines with lipid science expertise Euronext Paris Shares Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 02/04/2026 at 19:58, 8 months 25 days ago ABIONYX Reports Monthly Voting Rights and Shares Update Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
BRIEF published on 02/04/2026 at 19:58, 8 months 25 days ago Voting rights and shares of ABIONYX on Euronext Paris Euronext Paris Share Capital Voting Rights AMF ABIONYX
PRESS RELEASE published on 02/04/2026 at 19:53, 8 months 25 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement on total voting rights and shares. Company focuses on innovative medicines in rare diseases with lipid science expertise Shares Total Voting Rights Monthly Statement ABIONYX Pharma Innovative Medicines
BRIEF published on 01/28/2026 at 18:53, 9 months 4 days ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/23/2026 at 19:05, 9 months 9 days ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
BRIEF published on 01/23/2026 at 19:05, 9 months 9 days ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
PRESS RELEASE published on 01/23/2026 at 19:00, 9 months 9 days ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
BRIEF published on 01/07/2026 at 19:17, 9 months 25 days ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
Published on 10/30/2026 at 23:35, 2 days 8 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 8 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 13 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 16 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/02/2026 at 08:18, 6 minutes ago Score Capital AG reports strong growth in the first nine months of 2026: EBIT rises 63%, new business reaches EUR 171m
Published on 11/02/2026 at 08:10, 14 minutes ago STEICO SE: Change in the finance department – Ivica Rajković will succeed Georg Faller as CFO on 9 November 2026
Published on 11/02/2026 at 08:05, 19 minutes ago HIZENERGY Retains BloombergNEF Tier 1 Status Amid Tighter Q4 2026 Evaluation Criteria
Published on 11/02/2026 at 08:05, 19 minutes ago YeePay Explores New Approaches to Airline B2B Order Payments at IATA WFS & WPS 2026
Published on 10/30/2026 at 23:00, 2 days 9 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 14 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 20 hours ago Capital increase through exercise of subscription rights
